AL
HZNP

AJO LP’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

AJO LP’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,455
Closed -$399K – 269
2020
Q4 		$399K Sell
5,455
-87,718
-94% -$6.52M 0.04% 221
2020
Q3 		$7.24M Buy
93,173
+75,989
+442% +$5.23M 0.08% 216
2020
Q2 		$954K Buy
+17,184
New +$735K 0.01% 471
2019
Q4 		– Sell
-10,851
Closed -$294K – 713
2019
Q3 		$294K Sell
10,851
-340,439
-97% -$8.8M ﹤0.01% 521
2019
Q2 		$8.45M Sell
351,290
-188,355
-35% -$4.78M 0.04% 248
2019
Q1 		$14.3M Sell
539,645
-374,279
-41% -$8.87M 0.07% 207
2018
Q4 		$17.9M Buy
913,924
+5,838
+0.6% +$114K 0.1% 178
2018
Q3 		$17.8M Buy
908,086
+366,698
+68% +$6.97M 0.08% 191
2018
Q2 		$8.96M Buy
+541,388
New +$8.26M 0.04% 255
2017
Q2 		– Sell
-179,211
Closed -$2.65M – 669
2017
Q1 		$2.65M Sell
179,211
-36,334
-17% -$588K 0.01% 340
2016
Q4 		$3.49M Buy
+215,545
New +$3.91M 0.01% 306

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AJO LP's HZNP Position: Q1 2021 in Review

AJO LP sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 5,455 shares — an estimated $399K sold.

AJO LP first reported a position in HZNP in Q4 2016 and held it in 11 quarters. The position peaked at $17.9M in Q4 2018. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

  • AJO LP reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • AJO LP sold 5,455 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $399K.
  • AJO LP first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 11 quarters.
  • AJO LP's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $17.9M in Q4 2018.
  • 516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on AJO LP's 13F filing for Q1 2021, filed 7 May 2021.